Page 9 - Protein Sciences News Today

Simplify Asset Management Inc. lifted its holdings in shares of Bio-Techne Co. (NASDAQ:TECH – Get Rating) by 335.0% during the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 4,524 shares of the biotechnology company’s stock after purchasing an additional 3,484 shares […]

MINNEAPOLIS, May 25, 2023 /PRNewswire/ -- Bio-Techne Corporation today announced that Jim Hippel, Executive Vice President and Chief Financial Officer, will present at the 2023 Jefferies Healthcare... | May 25, 2023

StockNews.com initiated coverage on shares of Bio-Techne (NASDAQ:TECH – Get Rating) in a research note published on Thursday morning. The brokerage issued a hold rating on the biotechnology company’s stock. A number of other research analysts also recently weighed in on the stock. Robert W. Baird raised their price target on shares of Bio-Techne from […]

Sandhill Capital Partners LLC raised its holdings in Bio-Techne Co. (NASDAQ:TECH – Get Rating) by 291.4% during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 468,346 shares of the biotechnology company’s stock after purchasing an additional 348,675 shares during the period. Bio-Techne accounts […]

Sandhill Capital Partners LLC increased its stake in shares of Bio-Techne Co. (NASDAQ:TECH – Get Rating) by 291.4% in the 4th quarter, HoldingsChannel.com reports. The firm owned 468,346 shares of the biotechnology company’s stock after buying an additional 348,675 shares during the quarter. Bio-Techne comprises approximately 4.1% of Sandhill Capital Partners LLC’s portfolio, making the […]

Sit Investment Associates Inc. boosted its holdings in Bio-Techne Co. (NASDAQ:TECH – Get Rating) by 300.0% in the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 46,700 shares of the biotechnology company’s stock after buying an additional 35,025 shares during the period. Sit Investment […]

Sit Investment Associates Inc. lifted its stake in shares of Bio-Techne Co. (NASDAQ:TECH – Get Rating) by 300.0% during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 46,700 shares of the biotechnology company’s stock after buying an additional 35,025 shares during the quarter. Sit […]

Lord Abbett & CO. LLC raised its holdings in Bio-Techne Co. (NASDAQ:TECH – Get Rating) by 330.3% during the 4th quarter, HoldingsChannel reports. The institutional investor owned 332,452 shares of the biotechnology company’s stock after purchasing an additional 255,192 shares during the period. Lord Abbett & CO. LLC’s holdings in Bio-Techne were worth $27,553,000 as […]

Tredje AP fonden increased its holdings in Bio-Techne Co. (NASDAQ:TECH – Get Rating) by 350.1% in the 4th quarter, according to its most recent filing with the SEC. The institutional investor owned 31,707 shares of the biotechnology company’s stock after buying an additional 24,662 shares during the quarter. Tredje AP fonden’s holdings in Bio-Techne were […]

ImmunityBio (NASDAQ:IBRX – Get Rating) and Bio-Techne (NASDAQ:TECH – Get Rating) are both medical companies, but which is the superior investment? We will contrast the two businesses based on the strength of their earnings, institutional ownership, profitability, valuation, dividends, analyst recommendations and risk. Profitability This table compares ImmunityBio and Bio-Techne’s net margins, return on equity […]